This Viewpoint discusses artificial intelligence for treatment of diabetic retinopathy.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Dry Eye Disease Therapies at a Crossroads | 0 | 6.4 | 17-09-2026 |
| 2 | Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage | 0 | 16.79 | 20-08-2026 |
| 3 | Empagliflozin and the Risk of Retinopathy in Type 2 Diabetes | 0 | 11.22 | 01-01-2025 |
| 4 | Digital Defocus Vision Training Using Virtual Reality for Myopia Control | 0 | 9.14 | 27-08-2026 |
| 5 | Event-Based Progression Detection Among OCT, OCTA, and VF in Glaucoma | 0 | 9.28 | 03-09-2026 |
| 6 | Highly Aspherical Lenslets for Myopia Control | 0 | 6.82 | 20-08-2026 |
| 7 | rTG ω-3 Fatty Acids in Dry Eye Disease With MGD | 0 | 8 | 01-07-2024 |
| 8 | Language in the age of AI: Whimsymaxxing the apocalypse | 0 | 8.1 | 25-09-2026 |
| 9 | Разработку и внедрение ИИ в автономные системы обсудили на конференции в АлтГУ | 0 | 8.4 | 22-05-2026 |
| 10 | Use of artificial intelligence within the gambling field: a scoping review protocol [version 2; peer review: 2 approved] | 0 | 6.18 | 30-06-2026 |